Tübingen, Germany: CeGaT, a global provider of sequencing services for research, clinical studies, and human genetic diagnostics, is investing in new NovaSeq 6000 sequencing systems from Illumina. This acquisition is a strategically important move given CeGaT’s rapid corporate growth. CeGaT has acquired a sixth and seventh NovaSeq 6000 to meet the increasing demand for sequencing […]
SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced today the appointment of John Frank as the Company’s Chief Public Affairs Officer (CPAO). Frank joins Illumina on April 18 from Microsoft Corporation; he will report to Chief Executive Officer Francis deSouza. As Illumina’s Chief Public Affairs Officer, John […]
Ansa’s next-generation enzymatic DNA synthesis technology will dramatically accelerate innovation across every industry enabled by synthetic DNA from biologic drugs to biomanufacturing, and DNA-based data storage. Funding will advance next-generation technology platform, expand R&D and manufacturing facilities, grow multidisciplinary team, and launch DNA synthesis service. Ansa is solving current industry bottlenecks associated with synthesizing complex […]
Endava is leveraging its technical capabilities to support SOPHiA GENETICS in its mission to inform the best course of action for patients and research worldwide by democratizing data-driven medicine. SOPHiA GENETICS – a Swiss healthtech company listed on Nasdaq – have engaged Endava to support them in various IT projects across software engineering, technology operations and […]
London, UK — PCR Biosystems has expanded its comprehensive range of diagnostic reagents with the launch of the Lyo-Ready Probe 1-Step Kit, a lyophilisable 4x RT-qPCR reagent mix designed for ultra-sensitive high-throughput detection of RNA sequences. The new reagents will bring the exceptional sensitivity of the company’s liquid format 1-step RT-qPCR reagents to a freeze-dryable […]
Dublin, Ireland: ERS Genomics Limited (‘ERS’) is pleased to announce a license agreement with Central Institute for Experimental Animals (“CIEA”) in Japan. This is a non-exclusive licensing agreement granting CIEA access to the ERS CRISPR/Cas9 patent portfolio. ERS, co-founded by Dr. Emmanuelle Charpentier, 2020 Nobel Prize winner for gene-editing, provides access to the foundational CRISPR/Cas9 […]
Advanced Cybersecurity with State-of-the-Art Encryption Features and Biomanufacturing Compliance Enablement SEATTLE — NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the commercial unveiling of the nCounter® Pro Analysis System, the next generation of the nCounter instrument platform. The new system requires minimal bioinformatics support and […]
Version includes a powerful capability for genomic scar analysis for assessments of homologous recombination deficiency (HRD) that provides an efficient, consistent approach for analysis of tumor biomarkers used in pharmacogenomics and other cancer research SAN DIEGO — Bionano Genomics, Inc. (BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr® system and provider of NxClinical™ […]
Codetta’s digital spatial PCR platform will improve translational research and the development of new multi-omic diagnostics MORRISVILLE, N.C. — Codetta Biosciences, the pioneer in digital spatial polymerase chain reaction (dsPCR) and digital spatial immuno polymerase chain reaction (dsiPCR), announced today that it has raised $15 million in Series A financing, led by Anzu Partners with additional funding […]
CAMBRIDGE, Mass. & NEW YORK — Ultivue, an industry leader in multiplexing tools for tissue biomarker analysis, and Paige, the global leader in AI-based diagnostic software in pathology, today announced a partnership to collaborate on the co-development and co-marketing of AI-powered spatial immunophenotype capabilities to pharmaceutical and research customers. Collaborative efforts will initially focus on the […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
